| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8246365 | International Journal of Radiation Oncology*Biology*Physics | 2006 | 5 Pages |
Abstract
Conclusions: Proton beam therapy is a promising treatment modality for Stage I NSCLC, though locoregional relapse and late pulmonary toxicities in Stage IB patients were substantial. Further investigation of PBT for Stage I NSCLC is warranted.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Keiji M.D., Takashi M.D., Satoshi M.D., Hideki M.D.,